Alexza reports good results in schizophrenia study BusinessWeek - 2 Sep 2008 Alexza Pharmaceuticals said Tuesday its experimental drug significantly reduced symptoms of schizophrenia in a late-stage trial. The company reported that a ... UPDATE 1-Alexza schizophrenia drug meets main goal; shares rise Reuters Alexza's AZ-004 (Staccato(R) Loxapine) Phase 3 Trial Meets Primary ... MarketWatch Alexza Pharmaceuticals Inc announced its drug AZ-004 for the ... Network Médica RTT News all 20 news articles
Posted in Schizophrenia in the News |
Comments are closed.